Search Within

Patrick Dale Hilden

Formats
  1. Meeting Abstract (68)
  2. Journal Article (40)
Groups
  1. Center for Hematologic Malignancies (96)
  2. Department of Medicine (94)
  3. Hematologic Malignancies, Division of (89)
  4. Bone Marrow Transplant (78)
  5. Survivorship Research (64)
  6. Biostatistics Service (63)

More Groups

People
  1. Sergio Giralt (69)
  2. Miguel-Angel Perales (60)
  3. Molly Maloy (47)
  4. Ann Jakubowski (46)
  5. Esperanza Papadopoulos (44)
  6. Hugo Castro-Malaspina (44)

More People

Years
  1. 2021 (3)
  2. 2020 (5)
  3. 2019 (10)
  4. 2018 (21)
  5. 2017 (16)
  6. 2016 (18)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (42)
  2. Blood (30)
  3. Bone Marrow Transplantation (6)
  4. Journal of Clinical Oncology (4)
  5. International Journal of Radiation Oncology, Biology, Physics (3)
  6. Journal of Thoracic Oncology (3)

More Publications

Publishers
  1. Elsevier Inc. (48)
  2. American Society of Hematology (32)
  3. Nature Publishing Group (7)
  4. American Society of Clinical Oncology (5)
  5. John Wiley & Sons (3)
  6. Elsevier Ltd (2)

More Publishers

Results (108)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
    Journal Article

    Younes, A.; Hilden, P.; Coiffier, B.; Hagenbeek, A.; Salles, G.; Wilson, W.; Seymour, J. F.; Kelly, K.; Gribben, J.; Pfreunschuh, M.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in older patients with myelodysplastic syndromes
    Journal Article

    Getta, B. M.; Kishtagari, A.; Hilden, P.; Tallman, M. S.; Maloy, M.; Gonzales, P.; Castro-Malaspina, H.; Perales, M. A.; Giralt, S.; Tamari, R.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response
    Journal Article

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Dierov, D.; Nieves, J.; Garrett, M. D.; Sogani, J.; Cho, C.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Cardiovascular risk factors in survivors of childhood hematopoietic cell transplantation treated with total body irradiation: A longitudinal analysis
    Journal Article

    Friedman, D. N.; Hilden, P.; Moskowitz, C. S.; Suzuki, M.; Boulad, F.; Kernan, N. A.; Wolden, S. L.; Oeffinger, K. C.; Sklar, C. A.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation comorbidity index predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34(+) selected grafts for allogeneic hematopoietic cell transplantation
    Journal Article

    Barba, P.; Ratan, R.; Cho, C.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of rituximab for EBV viremia/post-transplant lymphoproliferative disease in CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Poppiti, K.; Lin, A.; Adel, N. G.; Hilden, P.; Castro-Malaspina, H.
    Blood (2016)

    Fulltext@MSK | Save
  • Prognostic factors of CLL patients undergoing reduced intensity allogeneic hematopoietic stem cell transplantation in the immunochemotherapy era
    Meeting Abstract

    Lahoud, O. B.; Hilden, P.; Maloy, M. A.; Dahi, P. B.; Castro-Malaspina, H.; Perales, M. A.; Giralt, S. A.; Sauter, C. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes
    Meeting Abstract

    Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save